Stella Pharma Corporation (4888.T)
JPY 555.0
(0.18%)
JPY 555.0
(0.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.11 Billion JPY | 18.68% |
| 2022 | 940.59 Million JPY | 21.58% |
| 2021 | 773.62 Million JPY | 96.91% |
| 2020 | 392.88 Million JPY | 28.5% |
| 2019 | 305.75 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.11 Billion JPY | -0.24% |
| 2023 Q3 | 1.04 Billion JPY | 14.54% |
| 2023 FY | 1.11 Billion JPY | 18.68% |
| 2023 Q2 | 908.42 Million JPY | -2.56% |
| 2023 Q1 | 932.3 Million JPY | -0.88% |
| 2023 Q4 | 1.11 Billion JPY | 7.28% |
| 2022 Q2 | 891.2 Million JPY | 0.0% |
| 2022 Q3 | 881.76 Million JPY | -1.06% |
| 2022 Q4 | 940.59 Million JPY | 6.67% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | -63.432% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -6125.98% |
| GNI Group Ltd. | 2.33 Billion JPY | 52.105% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 49.892% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -1554.178% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 0.412% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -978.154% |
| AnGes, Inc. | 1.61 Billion JPY | 30.917% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -1408.474% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 61.548% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -246.757% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -606560.87% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -696.529% |
| CanBas Co., Ltd. | 728 Thousand JPY | -153231.868% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -1170.451% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -654.538% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -1641.239% |
| Kidswell Bio Corporation | 875.65 Million JPY | -27.477% |
| PeptiDream Inc. | 2.4 Billion JPY | 53.57% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -20795.844% |
| Ribomic Inc. | 2.27 Million JPY | -48987.775% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -111625599900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -3000.711% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -3749.159% |
| CellSource Co., Ltd. | 305.92 Million JPY | -264.879% |
| FunPep Company Limited | 25.54 Million JPY | -4270.448% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -206.617% |
| TMS Co., Ltd. | 50.02 Million JPY | -2131.396% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -5240.682% |
| Cuorips Inc. | 1.04 Million JPY | -106923.586% |
| K Pharma,Inc. | 10.79 Million JPY | -10241.449% |
| Takara Bio Inc. | 11.85 Billion JPY | 90.58% |
| ReproCELL Incorporated | 248.14 Million JPY | -349.849% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -147.734% |
| StemCell Institute Inc. | 42.26 Million JPY | -2541.276% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -388.376% |
| CellSeed Inc. | 46.19 Million JPY | -2316.609% |